We are live on ! Find out more
SM

SG3 Management Portfolio holdings

AUM $6.45K
1-Year Est. Return 61.81%
This Fund
S&P 500
This Quarter Est. Return
+1.21%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
AUM
$693M
AUM Growth
-$53.2M
Cap. Flow
+$21.1M
Cap. Flow %
3.04%
Top 10 Hldgs %
46.29%
Holding
382
New
110
Increased
31
Reduced
28
Closed
176

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$32.7M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$18.7M
3
DIS icon
Walt Disney
DIS
+$14.1M
4
TSM icon
TSMC
TSM
+$6.86M
5
AMZN icon
Amazon
AMZN
+$6.38M

Sector Composition

Rank Sector Weight
1 Miscellaneous 79%
2 Technology 13.91%
3 Communication Services 5.2%
4 Healthcare 1.02%
5 Materials 0.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
W icon
101
CALL
Wayfair
W
$13.5B
$658K 0.1%
20,000
EOG icon
102
EOG Resources
EOG
$77.9B
$648K 0.09%
5,000
-40,800
-89% -$5.43M
GM icon
103
CALL
General Motors
GM
$75.1B
$639K 0.09%
19,000
HLF icon
104
CALL
Herbalife
HLF
$1.26B
$632K 0.09%
42,500
QURE icon
105
PUT
uniQure
QURE
$3.09B
$630K 0.09%
+27,800
New +$600K
CINC
106
CALL
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
$615K 0.09%
+50,000
New +$1.19M
EXAS
107
DELISTED
Exact Sciences
EXAS
$594K 0.09%
+12,000
New +$490K
LIT icon
108
CALL
Global X Lithium & Battery Tech ETF
LIT
$1.47B
$586K 0.08%
+10,000
New +$668K
IOVA icon
109
PUT
Iovance Biotherapeutics
IOVA
$4.19B
$575K 0.08%
+90,000
New +$703K
PTCT icon
110
PUT
PTC Therapeutics
PTCT
$5.55B
$573K 0.08%
+15,000
New +$624K
SAGE
111
CALL
DELISTED
Sage Therapeutics
SAGE
$572K 0.08%
+15,000
New +$573K
TSLA icon
112
Tesla
TSLA
$1.42T
$554K 0.08%
4,500
-172,700
-97% -$32.7M
ARWR icon
113
CALL
Arrowhead Research
ARWR
$11.7B
$548K 0.08%
+13,500
New +$447K
IOVA icon
114
CALL
Iovance Biotherapeutics
IOVA
$4.19B
$528K 0.08%
+82,600
New +$645K
BMRN icon
115
CALL
BioMarin Pharmaceuticals
BMRN
$12.7B
$517K 0.07%
5,000
+4,100
+456% +$385K
MRNA icon
116
CALL
Moderna
MRNA
$58.6B
$503K 0.07%
2,800
TLT icon
117
iShares 20+ Year Treasury Bond ETF
TLT
$46.6B
$498K 0.07%
+5,000
New +$504K
NVCR icon
118
PUT
NovoCure
NVCR
$1.81B
$469K 0.07%
6,400
+5,400
+540% +$406K
BKN
119
DELISTED
BlackRock Investment Quality Municipal Trust
BKN
$466K 0.07%
+40,000
New +$475K
ARWR icon
120
PUT
Arrowhead Research
ARWR
$11.7B
$458K 0.07%
+11,300
New +$374K
ALT icon
121
CALL
Altimmune
ALT
$642M
$456K 0.07%
27,700
+4,400
+19% +$49.4K
LTHM
122
DELISTED
Livent Corporation
LTHM
$447K 0.06%
22,500
+10,500
+88% +$287K
MIY icon
123
BlackRock MuniYield Michigan Quality Fund
MIY
$355M
$444K 0.06%
+40,000
New +$457K
MUJ icon
124
BlackRock MuniHoldings New Jersey Quality Fund
MUJ
$632M
$443K 0.06%
+40,000
New +$454K
MPA icon
125
BlackRock MuniYield Pennsylvania Quality Fund
MPA
$135M
$440K 0.06%
+40,000
New +$438K

Similar funds

SG3 Management's Q4 2022 Portfolio in Review

As of Q4 2022, SG3 Management held 382 positions worth $693M, down 7.1% from $746M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

SG3 Management deployed $21.1M of net new capital in Q4 2022, opening 110 new positions and adding to 31 existing holdings. Its largest new stake was Alphabet (Google) Class A: 232,500 shares worth $20.5M.

By sector, the portfolio is most concentrated in Miscellaneous at 79% of assets, down from 79% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Tesla, an estimated $32.7M trimmed.

  • SG3 Management's largest Q4 2022 buy was Alphabet (Google) Class A: 232,500 shares worth $20.5M.
  • SG3 Management added most to Microsoft in Q4 2022, an estimated $85.8M increase.
  • SG3 Management's biggest Q4 2022 reduction was Tesla, cutting an estimated $32.7M.
  • SG3 Management fully exited Alphabet (Google) Class C in Q4 2022, selling an estimated $18.7M.
  • SG3 Management's ten largest holdings make up 46% of its $693M portfolio in Q4 2022.
  • SG3 Management opened 110 new positions and closed 176 in Q4 2022.
  • SG3 Management's portfolio value fell 7.1% quarter-over-quarter to $693M.

Based on SG3 Management's 13F filing for Q4 2022, filed 14 Feb 2023.